Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in Africa. - Wikidata - awgldk - TriplyDB

Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in Africa.

Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in Africa.

http://www.wikidata.org/entity/Q38849598

about

Cryptococcal Disease in the Era of "Test and Treat": Is There Cause for Concern?Highlights of the 2017 European AIDS Clinical Society (EACS) Guidelines for the treatment of adult HIV-positive persons version 9.0.Effect of ready-to-use supplementary food on mortality in severely immunocompromised HIV-infected individuals in Africa initiating antiretroviral therapy (REALITY): an open-label, parallel-group, randomised controlled trial.When do coinfections matter?Priorities for Decreasing Morbidity and Mortality in Children With Advanced HIV Disease.Immunology of Cryptococcal Infections: Developing a Rational Approach to Patient Therapy.Risk factors affecting the mortality of HIV-infected patients with pulmonary tuberculosis in the cART era: a retrospective cohort study in China.Optimizing Clinical Trial Design to Maximize Evidence Generation in Pediatric HIV Late Presentation With HIV in Africa: Phenotypes, Risk, and Risk Stratification in the REALITY Trial Causes and Timing of Mortality and Morbidity Among Late Presenters Starting Antiretroviral Therapy in the REALITY Trial Managing Advanced HIV Disease in a Public Health Approach Rapid urine-based screening for tuberculosis in HIV-positive patients admitted to hospital in Africa (STAMP): a pragmatic, multicentre, parallel-group, double-blind, randomised controlled trial The tuberculosis-associated immune reconstitution inflammatory syndrome: recent advances in clinical and pathogenesis research Systems pharmacology reveals the unique mechanism features of Shenzhu Capsule for treatment of ulcerative colitis in comparison with synthetic drugs Predicting death and lost to follow-up among adults initiating antiretroviral therapy in resource-limited settings: Derivation and external validation of a risk score in Haiti

P2860

Q49672562-86E9E917-AB67-46F5-8859-F838949BBC01 Q51418627-26EFA3B4-070D-4D67-A774-C2DA9D2AB62D Q52589311-B2CEED10-C638-4C59-808A-FBCCC1821060 Q53835536-BC70E446-7C37-4EEB-87AC-49777FAA25F9 Q54260534-3419CDED-AFDE-4C3D-B052-02823A7BBBC8 Q54953513-E2E64431-A73A-49FC-84B6-95A452EE4DAA Q54962874-E637238B-9A28-47AF-A233-C685BD53756F Q56910418-EF241CBB-F318-4FB4-829D-6254F38A0A5A Q56912547-97F66046-098B-473B-82D0-7648D20FE68F Q56912555-6C7BEAD4-44E6-499F-9C16-D9AAA1A93DD5 Q56927385-AF3EB2A1-7229-4DB5-95DB-27EE1C12271C Q56931078-BA84909A-B1DD-4DA2-B739-FC81EA301B80 Q57128944-3BFE774F-F600-4B99-A050-CD7C6A24597A Q58577867-F09D7849-EEFD-4E47-8EA5-10D4E1E815A2 Q58696535-3939B1AB-57B0-4FFE-A375-BABB8D6F8BF4

P2860

Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in Africa.

http://www.wikidata.org/entity/Q38849598

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in Africa.

@en

type

label

Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in Africa.

@en

prefLabel

Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in Africa.

@en

P1433

Q38849598-2670C8DD-C404-40E6-B199-A85DD7BBEF66

P1476

Q38849598-31355E67-57EF-4A76-B964-2D32634CBFD8

P2093

Q38849598-03434994-0D86-41BD-9BEF-F5C81D594503

Q38849598-097F447D-852D-4F88-8E2D-E900FB6CD5D5

Q38849598-1B3DB4C3-5147-42C0-8CA6-EA40643B2E28

Q38849598-22F09DE9-34A3-4A70-89A1-CC72CD06F42C

Q38849598-2594A474-94CE-4111-B1D3-7B8B4EC7F761

Q38849598-3A2AF695-C589-4284-AC96-34CD34C20238

Q38849598-45CFEF12-F300-4AF1-8966-9D96C9282D60

Q38849598-553FA15B-B7A3-4F09-8831-B43317FE7E90

Q38849598-6435592C-E2BA-425A-A90A-F454B364F005

Q38849598-6B848FD9-DCE2-4881-B3B8-AADD8EBAD9EE

P2860

Q38849598-0D612F61-78D9-4D68-A772-2ABCE24B0176

Q38849598-1359A878-205E-4F50-B13A-FE50C5CF6498

Q38849598-166DC611-26E3-491A-B0FF-653367736A0A

Q38849598-1E603B21-1BD7-4A6A-9951-49CF10E1B755

Q38849598-25A6810E-2D38-4462-A2AA-E3537F6503E7

Q38849598-2A918B8E-A69A-4B5D-859C-0B70C6326311

Q38849598-3111D249-DB58-4770-B345-CADF7A2A89E8

Q38849598-665CC940-5933-4A08-BAF8-13DE3015FFDB

Q38849598-6C40E0FB-D916-4C4D-9548-94D7DA98058B

Q38849598-6E8A6EC3-5B0F-4F90-B9ED-4FC3A35B4503

P304

Q38849598-C8D75250-E833-40C7-B409-0CF2957B9C3C

P31

Q38849598-D87CFB0C-AEDC-4BE5-B482-6AA1A8DE5E4B

P356

Q38849598-9169B013-90B0-491F-BBDD-B211E6CF1A5E

P407

Q38849598-8EACBDD4-7CB5-44CF-BA59-857EE8BDB265

P433

Q38849598-43A60B24-ED65-4954-A1B0-CC8032CE6197

P478

Q38849598-0629B518-4F63-4A8D-989D-BE7D7F09DC48

P50

Q38849598-31FD5488-C8FD-4F2E-B8AF-0C5799D0F208

Q38849598-7D4FF187-3FF9-485E-882B-0A1ECF94F036

Q38849598-E3B7F46F-4746-4D59-A7CF-7416D2C4BEBB

Q38849598-F241C142-D3A2-4AD3-A1B3-6E804384136F

P577

Q38849598-A2D39D66-FE13-4D33-802E-5E2970EE75B8

P698

Q38849598-32EC52DC-6A3D-4A77-9302-078B3F5B4A43

P921

Q38849598-93434E27-18E1-478F-AFA5-C9345303FD34

P932

Q38849598-9B2D0F12-0F37-4D1A-BA41-68C70A4E450F

P356

P1433

The New England Journal of Medicine

P1476

Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in Africa.

@en

P2093

A Sarah Walker

http://www.w3.org/2001/XMLSchema#string

Abbas Lugemwa

http://www.w3.org/2001/XMLSchema#string

Abraham Siika

http://www.w3.org/2001/XMLSchema#string

Alex J Szubert

http://www.w3.org/2001/XMLSchema#string

Andrew J Prendergast

http://www.w3.org/2001/XMLSchema#string

Anna Griffiths

http://www.w3.org/2001/XMLSchema#string

Cissy Kityo

http://www.w3.org/2001/XMLSchema#string

Clara Agutu

http://www.w3.org/2001/XMLSchema#string

Diana M Gibb

http://www.w3.org/2001/XMLSchema#string

Godfrey Musoro

http://www.w3.org/2001/XMLSchema#string

P2860

How do Zimbabweans value health states?

Prevalence of tuberculosis in post-mortem studies of HIV-infected adults and children in resource-limited settings: a systematic review and meta-analysis

Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach

TB as a cause of hospitalization and in-hospital mortality among people living with HIV worldwide: a systematic review and meta-analysis

Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS

Adult meningitis in a setting of high HIV and TB prevalence: findings from 4961 suspected cases

Early mortality in adults initiating antiretroviral therapy (ART) in low- and middle-income countries (LMIC): a systematic review and meta-analysis

Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies

Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002-2007.

P304

233-245

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA1615822

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

377

http://www.w3.org/2001/XMLSchema#string

P50

Kathryn Maitland

Margaret Thomason

Mutsa Bwakura-Dangarembizi

P577

2017-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28723333

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

5603269

http://www.w3.org/2001/XMLSchema#string